Published in J Cardiovasc Pharmacol on March 01, 1988
Interaction of palmitoyl carnitine with calcium antagonists in myocytes. Br J Pharmacol (1989) 0.95
Modulating Effects of Spirulina platensis against Tilmicosin-Induced Cardiotoxicity in Mice. Cell J (2015) 0.86
Adverse outcome of using tilmicosin in a lamb with multiple ventricular septal defects. Can Vet J (2009) 0.81
Selective antagonism of calcium channel activators by fluspirilene. Br J Pharmacol (1990) 0.81
Pharmacogenetics: from bench to byte--an update of guidelines. Clin Pharmacol Ther (2011) 3.36
Selectivity of muscarinic antagonists in radioligand and in vivo experiments for the putative M1, M2 and M3 receptors. J Pharmacol Exp Ther (1987) 1.85
Prazosin and its analogues UK-18,596 and UK-33,274: a comparative study on cardiovascular effects and alpha-adrenoceptor blocking activities. Arch Int Pharmacodyn Ther (1980) 1.69
A comparison of the accumulation and release of 3H-ouabain and 3H-digitoxin by guinea-pig heart muscle. Br J Pharmacol Chemother (1968) 1.62
The central action of antihypertensive drugs, mediated via central alpha-receptors. J Pharm Pharmacol (1973) 1.56
Accumulation and release of 3H-digoxin by guinea-pig heart muscle. Br J Pharmacol Chemother (1967) 1.55
Pharmacogenetics: from bench to byte. Clin Pharmacol Ther (2008) 1.40
alpha 2 adrenoceptors: classification, localization, mechanisms, and targets for drugs. J Med Chem (1982) 1.38
Selectivity of some alpha adrenoceptor agonists for peripheral alpha-1 and alpha-2 adrenoceptors in the normotensive rat. J Pharmacol Exp Ther (1981) 1.35
Vascular smooth muscle contraction initiated by postsynaptic alpha 2-adrenoceptor activation is induced by an influx of extracellular calcium. Eur J Pharmacol (1981) 1.33
Mini-review. The postsynaptic alpha 2-adrenoreceptor. J Auton Pharmacol (1981) 1.32
Comparison between the acute hemodynamic effects and brain penetration of atenolol and metoprolol. J Cardiovasc Pharmacol (1980) 1.29
Possible subdivision of postsynaptic alpha-adrenoceptors mediating pressor responses in the pithed rat. Naunyn Schmiedebergs Arch Pharmacol (1979) 1.23
The kinetic behaviour of cardiac glycosides in vivo, measured by isotope techniques. J Pharm Pharmacol (1969) 1.18
Cardiovascular effects and interaction with adrenoceptors of urapidil. Arch Int Pharmacodyn Ther (1985) 1.18
Acute hypotensive action of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (St 155) after infusion into the cat's vertebral artery. Eur J Pharmacol (1967) 1.17
[On the problem of binding of H3-digoxin by myocardial tissue]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol (1967) 1.12
Influence of tramadol on neurotransmitter systems of the rat brain. Arzneimittelforschung (1996) 1.12
Aconitum sp. alkaloids: the modulation of voltage-dependent Na+ channels, toxicity and antinociceptive properties. Eur J Pharmacol (1997) 1.10
Ocular penetration of beta-adrenergic blocking agents. An experimental study with atenolol, metoprolol, timolol and propranolol. Doc Ophthalmol (1980) 1.10
Identification of vascular postsynaptic alpha 1- and alpha 2-adrenoceptors in man. Circ Res (1984) 1.09
Penetration of atenolol in the rabbit eye. Albrecht Von Graefes Arch Klin Exp Ophthalmol (1978) 1.08
Effect of converting enzyme inhibition and angiotensin receptor blockade on the vasoconstriction mediated by alpha 1-and alpha 2-adrenoceptor stimulation in pithed normotensive rats. Naunyn Schmiedebergs Arch Pharmacol (1982) 1.06
CYP2D6 and CYP2C19 activity in a large population of Dutch healthy volunteers: indications for oral contraceptive-related gender differences. Eur J Clin Pharmacol (1999) 1.06
Central hypotensive effect of alpha-methyldopa. J Pharm Pharmacol (1968) 1.04
The influence of 2-(2,6-dichlorphenylamino)-2-imidazoline hydrochloride (clonidine) and some related compounds on gastric secretion in the anaesthetized rat. Eur J Pharmacol (1970) 1.04
Central 5-HT1A receptors and the mechanism of the central hypotensive effect of (+)8-OH-DPAT, DP-5-CT, R28935, and urapidil. J Cardiovasc Pharmacol (1988) 1.03
Lipophilicity and brain disposition of clonidine and structurally related imidazolidines. Naunyn Schmiedebergs Arch Pharmacol (1977) 1.03
Modulation of noradrenaline release by peripheral presynaptic alpha 2-adrenoceptors in humans. J Cardiovasc Pharmacol (1987) 1.01
A lipophilic, selective alpha1 -adrenoceptor agonist: 2-(2-chloro-5-trifluoromethylphenylimino)imida-zolidine (St 587). Life Sci (1981) 1.00
[Calcium content of the myocardium in acute hypothermia]. Anaesthesist (1966) 0.99
Regional vascular effects of serotonin and ketanserin in young, healthy subjects. Hypertension (1988) 0.99
Organic and inorganic calcium antagonists reduce vasoconstriction in vivo mediated by postsynaptic alpha 2-adrenoceptors. Naunyn Schmiedebergs Arch Pharmacol (1981) 0.98
Comparative studies on central factors contributing to the hypotensive action of propranolol, alprenolol, and their enantiomers. Cardiovasc Res (1974) 0.98
Participation of cardiac presynaptic alpha 2-adrenoceptors in the bradycardiac effects of clonidine and analogues. Naunyn Schmiedebergs Arch Pharmacol (1981) 0.97
Orthostatic hypotension due to suppression of vasomotor outflow after amphetamine intoxication. Mayo Clin Proc (1996) 0.95
Centrally mediated hypotensive activity of B-HT 933 upon infusion via the cat's vertebral artery. Pharmacology (1980) 0.94
Hemodynamic characterization of pinacidil in rats. Comparison with hydralazine. Pharmacology (1983) 0.94
Extrasynaptic location of alpha-2 and noninnervated beta-2 adrenoceptors in the vascular system of the pithed normotensive rat. J Pharmacol Exp Ther (1982) 0.93
Calcium metabolism in atrial tissue during frequency potentiation and paired stimulation. Pflugers Arch (1970) 0.93
The contractions induced in rat and guinea-pig aortic strips by the alpha 2-adrenoceptor selective agonists B-HT 920 and UK 14,304 are mediated by alpha 1-adrenoceptors. Eur J Pharmacol (1984) 0.92
Interaction between centrally acting hypotensive drugs and tricyclic antidepressants. Arch Int Pharmacodyn Ther (1975) 0.90
Leflunomide in active rheumatoid arthritis: a prospective study in daily practice. Br J Clin Pharmacol (2004) 0.90
Serum concentration and urinary excretion of 3 H-ouabain and 3 H-digitoxin in patients suffering from hyperthyroidism or hypothyroidism. Klin Wochenschr (1970) 0.90
Calcium transport in isolated guinea-pig atria during metabolic inhibition. Biochim Biophys Acta (1967) 0.90
Mode of antinociceptive and toxic action of alkaloids of Aconitum spec.. Naunyn Schmiedebergs Arch Pharmacol (1998) 0.89
Deviating central hypotensive activity of urapidil in the cat. J Pharm Pharmacol (1985) 0.89
How safe are calcium antagonists in hypertension and coronary heart disease? J Hypertens (1996) 0.89
Alpha-adrenergic receptors in human blood vessels. Br J Clin Pharmacol (1986) 0.89
Serotonin-induced vasodilatation in the human forearm is mediated by the "nitric oxide-pathway": no evidence for involvement of the 5-HT3-receptor. J Cardiovasc Pharmacol (1993) 0.89
Effect of captopril on sympathetic neurotransmission in pithed normotensive rats. Eur J Pharmacol (1983) 0.89
Serum and saliva levels of 8-methoxypsoralen after rectal administration as a micro-enema. Br J Dermatol (1981) 0.89
The influence of alpha 1- and alpha 2-adrenoceptor agonists on cardiac output in rats and cats. J Pharm Pharmacol (1984) 0.88
The role of alpha 1-adrenoceptor subtypes in the phasic and tonic responses to phenylephrine in the longitudinal smooth muscle of the rat portal vein. Naunyn Schmiedebergs Arch Pharmacol (1991) 0.88
Interactions between the putative calcium entry promotor Bay k 8644 and pressor responses produced by alpha 1- and alpha 2-adrenoceptor agonists in the pithed normotensive rat. Naunyn Schmiedebergs Arch Pharmacol (1984) 0.88
Alpha-adrenoceptor control of peroxidase secretion from rat lacrimal gland cells in vitro. Exp Eye Res (1982) 0.88
Captopril impairs the vascular smooth muscle contraction mediated by postsynaptic alpha 2-adrenoceptors in the pithed rat. Eur J Pharmacol (1981) 0.88
Treatment of Raynaud's phenomenon. Eur Heart J (1993) 0.87
Dissociation constants of clonidine and structurally related imidazolidines. Arzneimittelforschung (1978) 0.87
Alpha-adrenoceptor stimulation and calcium movements. Blood Vessels (1987) 0.87
Comparison of the muscarinic receptors in the coronary artery, cerebral artery and atrium of the pig. Naunyn Schmiedebergs Arch Pharmacol (1989) 0.87
[On the tissue distribution, metabolism and excretion of cardiac glycosides]. Dtsch Med Wochenschr (1967) 0.87
The effect of some alpha-adrenoceptor antagonists on spontaneous myogenic activity in the rat portal vein and the putative involvement of ATP-sensitive K+ channels. Eur J Pharmacol (1992) 0.87
In vivo characterization of vasodilating muscarinic-receptor subtypes in humans. Circ Res (1994) 0.87
Effects of the selective beta 1-adrenoceptor antagonist, nebivolol, on cardiovascular parameters in the pithed normotensive rat. Pharmacology (1990) 0.87
Vasoconstriction mediated by postsynaptic alpha 2-adrenoceptor stimulation. Naunyn Schmiedebergs Arch Pharmacol (1980) 0.86
The interference of tricyclic antidepressants with the central hypotensive effect of clonidine. Eur J Pharmacol (1973) 0.86
The disposition of timolol in man. J Pharm Pharmacol (1978) 0.86
The influence of iproveratril on calcium movements in isolated heart muscle. Eur J Pharmacol (1971) 0.86
Interaction between beta 2-adrenoceptor-mediated vasodilation and alpha 2-adrenoceptor-mediated vasoconstriction in the pithed normotensive rat. J Cardiovasc Pharmacol (1983) 0.86
Angiotensin II receptor antagonists (AT1-blockers, ARBs, sartans): similarities and differences. Neth Heart J (2006) 0.86
The hypotensive activity and side effects of methyldopa, clonidine, and guanfacine. Hypertension (1984) 0.85
Hypotensive activity of serotonin antagonists; correlation with alpha 1-adrenoceptor and serotonin receptor blockade. Life Sci (1983) 0.85
Differences between exogenous and endogenous noradrenaline in the effects on vascular post-synaptic alpha 1- and alpha 2-adrenoceptors in man. J Hypertens Suppl (1985) 0.85
Effects of 5-hydroxytryptamine on capillary and arteriovenous anastomotic blood flow in the human hand and forearm and in the pig hind leg. J Cardiovasc Pharmacol (1991) 0.85
Differential effects of the calcium entry blocker D 600 on contractions of rat and guinea-pig aortas, elicited by various alpha-1 adrenoceptor agonists. J Pharmacol Exp Ther (1984) 0.85
Positive chronotropic activity of angiotensin II in the pithed normotensive rat is primarily due to activation of cardiac beta 1-adrenoceptors. Naunyn Schmiedebergs Arch Pharmacol (1988) 0.85
The role of beta 2-adrenoceptors in the IOP-lowering effect of adrenaline. Graefes Arch Clin Exp Ophthalmol (1982) 0.85
Assessment of peripheral vascular effects of antimigraine drugs in humans. Cephalalgia (1995) 0.85
Serum and urine concentrations of 5-methoxypsoralen after oral administration. Br J Dermatol (1981) 0.85
Vascular responsiveness in isolated perfused kidneys of diabetic hypertensive rats. J Hypertens (1996) 0.85
Effects of the irreversible alpha-adrenoceptor antagonists phenoxybenzamine and benextramine on the effectiveness of nifedipine in inhibiting alpha 1- and alpha 2-adrenoceptor mediated vasoconstriction in pithed rats. Naunyn Schmiedebergs Arch Pharmacol (1985) 0.85
Inhibition of facilitation of sympathetic neurotransmission and angiotensin II-induced pressor effects in the pithed rat: comparison between valsartan, candesartan, eprosartan and embusartan. J Hypertens (2001) 0.85
Comparison of the effects of urapidil and sodium nitroprusside on haemodynamic state, myocardial metabolism and function in patients during coronary artery surgery. Br J Anaesth (1996) 0.84
[Pharmacological and biochemical effects of hydralazine and dihydralazine]. Arzneimittelforschung (1968) 0.84
Significant food interactions observed with a nifedipine modified-release formulation marketed in the European Union. Int J Clin Pharmacol Ther (2006) 0.84
In vivo characterization of muscarinic receptor subtypes that mediate vasodilatation in patients with essential hypertension. Hypertension (1995) 0.84
Association between HTR2C gene polymorphisms and the metabolic syndrome in patients using antipsychotics: a replication study. Pharmacogenomics J (2010) 0.84
Sgd 101/75 is distinguished from other selective alpha 1-adrenoceptor agonists by the inhibition of its pressor responses by calcium entry blockade and vasodilatation in pithed rats and cats. Eur J Pharmacol (1983) 0.84
Comparative vasoconstrictor effects of angiotensin II, III, and IV in human isolated saphenous vein. J Cardiovasc Pharmacol (1997) 0.84